We are live on ! Find out more
KMTS

Kestra Medical Technologies

107 hedge funds and large institutions have $1.49B invested in Kestra Medical Technologies in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 6

364% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 11

34% more funds holding

Funds holding: 80107 (+27)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

30% more capital invested

Capital invested by funds: $1.15B → $1.49B (+$339M)

2.17% more ownership

Funds ownership: 94.07%96.23% (+2.2%)

Holders
107
Holders Change
+27
Holders Change %
+33.75%
% of All Funds
1.3%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
33
Increased
51
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$5.11M -$1.71M -66,474 -26%
GCM
27
Ghisallo Capital Management
Massachusetts
$4.69M +$2.63M +101,992 +136%
TD Asset Management
28
TD Asset Management
Ontario, Canada
$3.52M +$1.04M +40,554 +44%
Northern Trust
29
Northern Trust
Illinois
$3.51M +$852K +33,101 +33%
Charles Schwab
30
Charles Schwab
California
$3.17M +$295K +11,464 +11%
BG
31
Bellevue Group
Switzerland
$3.07M -$334K -12,956 -10%
Alyeska Investment Group
32
Alyeska Investment Group
Illinois
$2.65M +$2.58M +100,000 New
SGM
33
Seven Grand Managers
New York
$2.65M +$2.58M +100,000 New
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.34M +$878K +34,091 +65%
Morgan Stanley
35
Morgan Stanley
New York
$2.27M +$1.07M +41,587 +95%
Bank of America
36
Bank of America
North Carolina
$1.49M +$890K +34,574 +160%
Walleye Capital
37
Walleye Capital
New York
$1.41M +$1.14M +44,393 +502%
BGM
38
Burkehill Global Management
New York
$1.33M +$1.29M +50,000 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.26M +$358K +13,917 +41%
Los Angeles Capital Management
40
Los Angeles Capital Management
California
$1.19M +$1.09M +42,489 New
Citadel Advisors
41
Citadel Advisors
Florida
$1.16M +$1.12M +43,643 New
Barclays
42
Barclays
United Kingdom
$1.09M +$580K +22,507 +121%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.05M +$1.02M +39,600 New
SPC
44
Sigma Planning Corp
Michigan
$670K
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$665K +$502K +19,476 +348%
LGM
46
Lykos Global Management
Connecticut
$663K +$644K +25,000 New
N
47
Nuveen
North Carolina
$622K +$162K +6,291 +37%
Wells Fargo
48
Wells Fargo
California
$593K +$343K +13,325 +148%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$530K +$494K +19,170 +2,335%
JP Morgan Chase
50
JP Morgan Chase
New York
$525K +$138K +5,364 +37%

KMTS Hedge Fund Activity: Q4 2025 in Review

107 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q4 2025, worth a combined $1.49B — up 30% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KMTS positions and 6 closed out — a net gain of 27 holders — while 51 added to existing stakes and 11 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $65.2M. The largest seller was Bain Capital Investors, cutting an estimated $47.6M.

  • 107 institutional investors held Kestra Medical Technologies (KMTS) as of Q4 2025, up from 80 in Q3 2025.
  • Funds reported $1.49B of Kestra Medical Technologies stock for Q4 2025, up 30% quarter-over-quarter.
  • 33 funds opened new Kestra Medical Technologies positions in Q4 2025 and 6 closed out, a net change of +27 holders.
  • The largest Kestra Medical Technologies buyer in Q4 2025 was T. Rowe Price Associates, an estimated $65.2M added.
  • The largest Kestra Medical Technologies seller in Q4 2025 was Bain Capital Investors, an estimated $47.6M sold.

Based on aggregated 13F filings for Q4 2025.